Concord Biotech Recommends 1:1 Bonus Issue: Existing Investors to Receive Free Share

Ahmedabad-headquartered active pharmaceutical ingredients (API) and biopharma manufacturer Concord Biotech Limited has delivered a major corporate reward for its equity investors by approving a 1:1 bonus share proposal. Under the approved capital restructuring initiative, the enterprise aims to double the liquidity of its shares in the market while expanding its public equity base by allocating additional shares directly to eligible portfolio holders without any supplementary cash outlay.

Mechanics of the 1:1 Bonus Share Ratio and Face Value

Under the recommended entitlement framework, eligible shareholders of Concord Biotech will be entitled to receive one fresh fully paid-up equity bonus share for every single existing fully paid-up equity share they hold on the official record date. Each newly allotted bonus share carries a face value of ₹1, aligning directly with the existing nominal capital structure of the listed company. Under this allocation dynamic, an investor possessing 100 equity shares on the qualifying date will see their total portfolio holding double to 200 shares following the credit of the bonus allotment, significantly boosting overall float and retail market liquidity.

Funding via Share Premium Reserves and Shareholder Clearance

The issuance of these bonus equity shares will be financed by capitalizing available reserves currently standing in the company's share premium account. The execution of the corporate action remains subject to formal shareholder clearance via postal ballot or voting mechanisms, in accordance with the regulatory standards outlined by the Securities and Exchange Board of India (SEBI) and provisions of the Companies Act.

Timeline for Record Date Announcement and Investor Eligibility

The corporate disclosure confirms that the definitive record date to identify eligible investors for the bonus distribution will be determined and notified separately by the company's Board of Directors. Investors seeking to benefit from the bonus allotment must ensure delivery of the shares into their respective demat accounts prior to the upcoming record date cut-off. Further formal communications detailing the statutory voting window, compliance timeline, and demat credit schedules are slated to be submitted to the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) in subsequent filings.